Innate Pharma announces conference call and webcast for third quarter 2024 results and business updates

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the Company will hold a conference call on Wednesday, November 13, 2024, at 2 p.m. CET / 8 a.m. ET, to give an update on business progress during the third quarter of 2024.

Participants during the call will be: 
•    Jonathan Dickinson, Chief Executive Officer
•    Sonia Quaratino, Executive Vice President, Chief Medical Officer
•    Yannis Morel, Executive Vice President, Chief Operating Officer
•    Frédéric Lombard, Senior Vice President, Chief Financial Officer
•    Arvind Sood, Executive Vice President, President of US Operations

Details for the Virtual Event:

The live webcast will be available at the following link: 
https://events.q4inc.com/attendee/381945831

Participants may also join via telephone using the following registration link: https://registrations.events/direct/Q4I280043.

This information can also be found on the Investors section of the Innate Pharma website, www.innate-pharma.com. A replay of the webcast will be available on the Company website for 90 days following the event.